Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

Clinical trial NCT06714604 · RECRUITING

Trial details

NCT number: NCT06714604
Sponsor: Sahlgrenska University Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Adenocarcinoma Borderline Resectable Pancreatic Carcinoma Pancreas Cancer Neoadjuvant Chemotherapy Surgery Pancreatectomy

Start date: 2023-10-18
Primary completion: 2032-12-31
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.